Condition
Breast Ductal Carcinoma In Situ clinical trials and research
As of November 12, 2026, Find a Trial lists 8 Breast Ductal Carcinoma In Situ clinical trials that are recruiting, in United States. By phase: Phase 2 (3), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 1Country
Newest Breast Ductal Carcinoma In Situ clinical trials
All recruiting trials (8)
-
A program to help women navigate breast cancer care
This study tests a support program designed to help underserved women with breast cancer find the care they need and improve their quality of life.
-
Using low dose tamoxifen with or without omega-3 fatty acids to reduce breast cancer risk
This study is testing whether adding omega-3 fatty acids to low dose tamoxifen can help reduce the risk of breast cancer in overweight or obese postmenopausal women.
-
Finding the best dose of tamoxifen to reduce breast cancer risk in premenopausal women
This study is testing if a higher dose of tamoxifen can help premenopausal women at higher risk for breast cancer by reducing breast density on mammograms.
-
Comparing acolbifene and low dose tamoxifen to prevent breast cancer in high-risk premenopausal women
This study is testing whether acolbifene or low dose tamoxifen can help prevent breast cancer in high-risk premenopausal women.
-
Caloric restriction combined with targeted radiation therapy for early stage breast cancer
This study is testing if cutting calories while getting targeted radiation therapy can help reduce tumor size more in people with early stage breast cancer compared to just the radiation alone.
-
Identifying and caring for individuals with inherited cancer syndromes
This study is testing whether free genetic testing can help find and support people with inherited cancer syndromes better than current methods.
-
Impact of COVID-19 on financial costs for breast cancer surgery patients
This study looks at how the COVID-19 pandemic has impacted the out-of-pocket costs and financial struggles of breast cancer patients undergoing surgery.
-
Vaccine treatment before surgery for HER2-expressing ductal carcinoma in situ
This study is testing a new vaccine given before surgery to see if it can help boost the immune response in patients with a specific type of breast cancer called HER2-expressing ductal carcinoma in situ.
Related topics
Quick answers
How many Breast Ductal Carcinoma In Situ clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.